Posted in | News

Investment for Ceratech Sustainable Concrete Admixture for High Strength, Fast Setting Concrete

W. R. Grace and Co. today announced the completion of a strategic investment in CERATECH, Inc., a Maryland-based firm that has developed green, sustainable concrete admixture technologies for formulating high strength, fast setting concrete primarily using fly ash, a waste stream product from coal fired power plants. CERATECH technology uniquely enables the production of environmentally friendly, high performance concrete. Under terms of the investment, Grace also has exclusive rights to market CERATECH products and technology in the manufactured concrete market.

Grace currently manufactures a wide range of products for commercial and residential construction markets, including concrete admixtures, cement additives, roofing underlayments, fire protection products, air barrier systems, and below grade structural waterproofing systems. Collectively, these products help make homes and buildings stronger, safer and more comfortable. CERATECH’s green, sustainable concrete admixture technology was first commercialized in 2001 in an effort to utilize waste stream fly ash to make high performance concrete repair materials.

“Our investment in this new technology is the latest step in expanding our portfolio of green materials for the construction industry,” said Andrew Bonham, President, Grace Construction Products. “We expect CERATECH technology combined with Grace’s extensive technical expertise and strong customer relationships in the cement and concrete industry will accelerate growth for both companies.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.